ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,250Medicare Part D Prescriptions Filled, Including Refills

Rank: 240 out of 1233

$606K Total Retail Price of All Prescriptions

Rank: 222 out of 1233

620 Patients Receiving at Least One Drug in Part D
72% Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in South Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 620 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 620 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
FUROSEMIDE 289 226 71 1 9
AMLODIPINE BESYLATE 278 232 63 2 1
LEVOTHYROXINE SODIUM 253 221 50 3 3
POTASSIUM CHLORIDE 203 139 40 4 21
FAMOTIDINE* 202 145 36 5 74
HYDROCODONE-ACETAMINOPHEN 199 125 65 S3 6 2
SIMVASTATIN 190 142 45 7 6
METOPROLOL TARTRATE 176 152 35 8 11
GABAPENTIN 176 104 38 8 13
ATORVASTATIN CALCIUM 174 123 43 10 7
CLOPIDOGREL 163 125 34 11 18
WARFARIN SODIUM 160 135 25 12 25
PRAVASTATIN SODIUM 136 95 33 13 8
METOPROLOL SUCCINATE 136 108 29 13 20
HYDROCHLOROTHIAZIDE 129 118 26 15 12
PREDNISONE 115 83 43 16 37
LISINOPRIL 107 90 31 17 4
OMEPRAZOLE 105 85 31 18 5
ALPRAZOLAM 104 80 35 B 19 14
CRESTOR 100 76 22 20 28
METFORMIN HCL 97 40 26 21 10
TRIAMTERENE-HCTZ 96 48 15 22 80
NIFEDIPINE ER 94 66 22 23 96
COLCRYS 94 71 24 23 105
ALLOPURINOL 91 75 17 25 33
NAMENDA 90 90 16 26 40
METFORMIN HCL ER 88 48 21 27 41
CARVEDILOL 87 65 23 28 26
DIGOX 84 70 16 29 109
GLIMEPIRIDE 83 63 22 30 51
KLOR-CON M20 80 52 22 31 63
ISOSORBIDE MONONITRATE ER 77 72* 15 32 58
MELOXICAM 70 37 18 33 30
DIOVAN 70 54 16 33 45
RANITIDINE HCL 70 37 18 33 19
VALSARTAN-HYDROCHLOROTHIAZIDE 69 40 19 36 54
SERTRALINE HCL 65 46 18 37 29
VERAPAMIL ER 64 38 13 38 111
BACLOFEN 63 <11 <11 39 140
LOSARTAN POTASSIUM 62 <11 <11 40 22
POLYETHYLENE GLYCOL 3350 61 50 20 41 68
MIRTAZAPINE 61 <11 <11 41 61
JANUVIA 60 37 16 43 67
CYCLOBENZAPRINE HCL 60 30 25 R 43 66
DONEPEZIL HCL 60 60 12 43 39
PANTOPRAZOLE SODIUM 59 46 20 46 43
NOVOLOG MIX 70-30 59 31 13 46 228
ATENOLOL 58 <11 <11 48 32
METOCLOPRAMIDE HCL 57 29 14 49 137
NEXIUM 57 52* 15 49 23
TRAMADOL HCL 56 51* 23 51 15
ZETIA 55 35 13 52 79
INSULIN SYRINGE* 55 <11 <11 52 206
FINASTERIDE 54 <11 <11 54 125
QUETIAPINE FUMARATE 52 29 11 A 55 71
CLONAZEPAM 51 <11 <11 B 56 34
ESCITALOPRAM OXALATE 50 <11 <11 57 47
LEVETIRACETAM 50 20 11 57 121
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 18, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.